Peer-influenced content. Sources you trust. No registration required. This is HCN.
Myasthenia Gravis News
This case highlights how important it is to consider neurological variables when shortness of breath cannot be explained by cardiac or respiratory problems in acute situations.
Emergency Medicine November 11th 2025
Medical Professionals Reference (MPR)
Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines and superior for each of the 9 serotypes unique to Capvaxive.
Cardiology September 16th 2025
Infectious Disease Advisor
Future monitoring of VE is required to support ongoing policy decisions around the implementation of COVID-19 vaccines.
Family Medicine/General Practice August 27th 2025
“With two large phase 3 studies now demonstrating a consistent and significant efficacy profile for AD109, we are closer to delivering the first oral pharmacotherapy for over 80 million US adults with OSA.”
Family Medicine/General Practice August 20th 2025
Epoch Health
“For these five groups of people, ibuprofen poses serious health risks that outweigh potential benefits.”
Cardiology July 29th 2025
The Nurse Practitioner
The report emphasizes that COPD results from gene-environment interactions over time, with environmental factors including tobacco smoking and air pollution being primary drivers, while genetic factors like alpha-1 antitrypsin deficiency represent rare but significant risk factors.
Family Medicine/General Practice July 17th 2025